Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called blood product.
North America is the largest supplier of Blood Product, with production revenue market share about 60%, and the sales market share is 40% in 2015. That is to say, there are a large number of exports in North America, while North America also is the largest consumption region.
Market Analysis and Insights: Global Blood Product Market
In 2019, the global Blood Product market size was US$ 31800 million and it is expected to reach US$ 61610 million by the end of 2026, with a CAGR of 9.8% during 2021-2026.
Global Blood Product Scope and Market Size
Blood Product market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Blood Product market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Blood Product market is segmented into Albumin, Immune Globulin, Coagulation Factor, Others, etc.
Segment by Application, the Blood Product market is segmented into Immunity, Therapy, Surgery, Other, etc.
Regional and Country-level Analysis
The Blood Product market is analysed and market size information is provided by regions (countries).
The key regions covered in the Blood Product market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.

Competitive Landscape

and Blood Product Market Share Analysis
Blood Product market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Blood Product business, the date to enter into the Blood Product market, Blood Product product introduction, recent developments, etc.
The major vendors include Baxter, CSL, Grifols, Octapharma, BPL, Kedrion, Mitsubishi Tanabe, CBOP, RAAS, Hualan Bio, etc.

This report focuses on the global Blood Product status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Blood Product development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

Baxter
CSL
Grifols
Octapharma
BPL
Kedrion
Mitsubishi Tanabe
CBOP
RAAS
Hualan Bio

Market segment by Type, the product can be split into

Albumin
Immune Globulin
Coagulation Factor
Others

Market segment by Application, split into

Immunity
Therapy
Surgery
Other

Market segment by Regions/Countries, this report covers

North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:

To analyze global Blood Product status, future forecast, growth opportunity, key market and key players.
To present the Blood Product development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Blood Product are as follows:
History Year: 2015-2019

Base Year:

2019

Estimated Year:

2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.